Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

WCAAD 2019

About Conference


ConferenceSeries LLC Ltd invites people from all across the world to the 14th World Congress on Advances in Alzheimers and Dementia, an esteemed conference scheduled during May 15-16, 2019 at Melbourne, Australia incorporating the theme: Acquainting the latest Innovations and global perspectives to maintain neurohealth. We welcome all the eminent researchers, students and Business delegates to take part in the Conference to witness and share new advancements and directions contribute to the future improvements  in the field of Alzheimers and Dementia

Conference Series LLC Ltd is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80,000 editorial board members, and 7.5 million followers to its credit.

Why to attend:

WCAAD 2019 is an provides an opportunity to all the Neurologist, Neurosurgeons, Psychiatrist, Neuroscientist, Professors , Directors, Member of Associations, Industrial Leaders, Consultants, Researchers, , Doctors, and social orders, Pharmaceutical company organization and industrialists and other people related to the corresponding field to share academic and clinical developments and research and to build on social interactions and support each other in creating awareness about the leading advancements and therapies for the reduction of patients with Alzheimer's, Dementia

WCAAD 2019 gives a splendid platform by means of collecting eminent professors, researchers, students and delegates to alternate new thoughts. The convention will cover a wide variety of topics and allow participants to speak about approximately the control of diseases. Best poster presenters could be judged and presented for the duration of the conference. To inspire wide participation from all around the world Conference Series llc Ltd is offering reduced registration price for college students. The meeting can be worried sessions via world elegance professionals in the subject of neurology. In Alzheimer’s Congress 2019, worldwide symposiums, B2B gatherings, worldwide workshops will likewise be looked after out to speak approximately the precise factors within the area of Alzheimer's Disease and Dementia and Neurology.

Target Audience:

  • Neurologists and Executives
  • Physicians
  • Neuroscientists
  • Neuro science students
  • Specialists
  • researchers
  • Professors
  • Industrial Specialists
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Researchers
  • Lecturers and Understudies scholars

Sessions / Tracks

Track 1: Alzheimer’s Disease:

Alzheimer’s Disease Is a commonest degenerative brain disorder which is the most common form of dementia accounting to major percent of dementia cases in the world, it effects innumerable number of people each year and it occurs due to degeneration of brain neurons in the cerebral cortex and presence of neurofibrillary tangles and plaques containing beta-amyloid cells. The disease was first described by Dr.Alios Alzheimer, a German physician. The disease destroys the brain ability to reason, remember, Imagine and learn. The progression of dementia is broken as preclinical, before symptoms appear there is mild cognitive impairment, when symptoms are mild dementia. The cause of Alzheimers is unknown however several factors are thought to be implicated in this disease. Memory loss is the primary and early symptom along with a gradual decline of other cognitive functions.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019.

 

Track 2: Dementia:

Dementia is a clinical syndrome which reasons a progressive deterioration of mind, conduct and character causing global impairment due to diffuse disorder of cerebral hemisphere maximally effecting the cortex and hippocampus. It occurs most usually in aged than in middle-aged. Dementia is a symptom of disease instead of a single entity. Depression can mimic the preliminary stages of dementia and it's far termed ’pseudodementia. Types of dementia encompass cortical, subcortical and progressive

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy

 

Track 3: Vascular Dementia:

Vascular dementia also be referred to as vascular cognitive impairment is the second maximum common reason of dementia and happens because of reduced blood glide to the mind because of diseased vessels causing a slow decline in the questioning competencies. Some people have both vascular dementia and Alzheimer’s sickness – often known as mixed dementia. A growing number of specialists select the term "vascular cognitive impairment (VCI)" to "vascular dementia" because they sense it higher expresses the idea that vascular thinking adjustments can variety from moderate to excessive. Many specialists accept as true with that vascular dementia remains underdiagnosed — like Alzheimer's disease — although it's identified as commonplace. Vascular Dementia is more common in men than women and usually happens at a younger younger than alzheimers. The signs of vascular dementia get worse over time. In the later stages the signs and symptoms become more great. Brain scans consisting of CT or MRI can be beneficial in giving a analysis of vascular dementia. This is due to the fact they permit doctors to look for modifications in blood vessels that are commonplace on this type of dementia.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019;; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019.

 

Track 4: Causes and Risk factors:

The causes of alzheimers disease are unknown is caused by brain cell death however there are several risk factors that increase the prevalence of the disease which include neurochemical factors, environmental, genetic and immunological. Unavoidable risk factors include aging, family history, gender. exposure to environmental contaminants, such as toxic metals, pesticide, and industrial chemicals may increase the potency of the risk factors. The untreatable and irreversible factors of dementia include Degenerating disorders of the CNS, Parkinson’s disease and Alzheimers disease and the treatable and reversible causes include metabolic and endocrine disorders, infections and intoxification, Primary and metastatic tumor may also lead to the cause of dementia.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related conferences: 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019

 

Track 5: Pathophysiology and Disease Mechanisms:

Alzheimer's disorder is characterized by means of lack of neurons and synapses within the cerebral cortex and subcortical regions. This loss results in gross atrophy of the affected areas, consisting of degeneration in the temporal lobe and parietal lobe, and components of the frontal cortex and cingulate gyrus. The three steady neuropathological hallmarks of AD consist of Amyloid-wealthy senile plaques, Neurofibrillary tangles, Neuronal degeneration. The gross pathophysiologic changes consist of: enlarged ventricles, cortical atrophy and basal ganglia losing. The pathophysiology of dementia varies from individual to individual but there are fairly positive essential additives that continue to be identical for all the patients.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019

 

Track 6: Signs and Symptoms of Alzheimers and Dementia:

Dementia signs and symptoms vary relying at the motive, but commonplace signs and symptoms. One of the maximum common symptoms of Alzheimers is the memory loss that disrupts day by day life. Other signs and symptoms consist of change in imaginative and prescient, intellectual slowing of concentration, Loss of spontaneity and experience of initiative, Increased tension and/or aggression. Moderate symptoms may also lead to complex issues like Hallucinations, delusions, and paranoia, impulsive behavior and the extreme signs and symptoms consist of Inability to communicate Weight loss, Seizures, Skin infections, Difficulty swallowing, Groaning, moaning, or grunting, Increased snoozing, Loss of bowel and bladder manipulate.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy

 

Track 7: Geriatrics Dementia and Cognitive Disorder:

Geriatric medication involves the construction of better long term care for the elderly to ensure that they are given with proper medication for the safe functioning of the body. Cognitive disorders are a category of mental health disorders that primarily affect learning, memory, perception, and problem solving which include conditions like amnesia, dementia, and delirium. These disorders impairs the cognizance function of an individual to the point where normal functioning of the brain is impossible without giving treatment. Delirium is a state of medical emergency  that results in confused environment and emotional disruption  making the person unable to think, sleep or pay attention and this condition is observed during dementia or after surgery. Some not unusual cognitive problems include Dementia, Developmental issues, Motor skill issues, Amnesia, Substance-induced cognitive impairment. Dementia and Geriatric Cognitive Disorders contemplates on Huntington’s chorea, Alzheimer’s and Parkinson’s disease, and many other neurodegenerative diseases

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019.

 

Track 8: Animal Models and Translational Medicine:

The necessity for a deeper information of neurological diseases consisting of Alzheimer’s ailment that boom in frequency as a feature of age has become of paramount significance with the approaching generation and the growing social demands for individuals to perform higher and longer The impact of this disorder on thousands and thousands of individuals, their households, and the fitness care gadget can be devastating. As such, the medical community has strived to version AD in the desire that those fashions will offer the gear for powerful and desperately wished therapeutic improvement and trying out. Genetically modified animal models have helped to boost our knowledge of the underlying mechanisms of disease and have demonstrated to be invaluable inside the preclinical assessment of ability therapeutic interventions and those fashions lead to the Significant insights into the characteristic of genes in Alzheimer disease and related dementias. Although none of the present models fully reproduces the entire spectrum of this insidious human disease, crucial factors of Alzheimer pathology and ailment processes can be experimentally recapitulated. Animal models have played a chief role in defining essential disease-associated mechanisms and had been at the leading edge of evaluating novel therapeutic tactics, with many treatments currently in medical trial owing their origins to studies first of all finished in mice.  Transgenic mouse models have ruled the research of this disease but their validity may be wondered. Numerous opportunity models exist that may provide precious facts on the molecular and cellular basis of Alzheimer’s disease

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy

 

Track 9: Alzheimers Disease and Type 2 Diabetes:

The danger of developing dementia is twice as extremely good in diabetic sufferers and many scientist suggest that the danger is extra in patients with type 2 diabetes. Diabetes is considered a risk factor for vascular dementia. When diabetes isn't controlled, an excessive amount of sugar stays inside the blood which over the years damages the organs of the frame which include the  brain harm that is often due to reduced or blocked blood go with the flow on your mind. The mind relies upon on many distinctive chemical substances, which may be unbalanced by an excessive amount of insulin. Some of these changes may additionally help cause Alzheimer’s disease additionally High blood sugar causes inflammation which might also harm mind cells and help Alzheimer’s to broaden. Preventing diabetes might not forestall Alzheimer’s from developing. But easy life-style adjustments can assist keep away from diabetes and cut the threat.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019;; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019.

 

Track 10: Amyloid Protein in Alzheimer’s and Dementia:

Amyloid is the protein this is produced obviously via the mind all through ones lifetime, but generally degrades. On the mind of Alzheimers patients , amyloid accumulates and this accumulation destroys mind cells. The formation of amyloid plaques and neurofibrillary tangles are concept to make contributions to the degradation of the neurons (nerve cells) in the brain and the following symptoms of Alzheimer's disorder. One of the hallmarks of Alzheimer's ailment is the buildup of amyloid plaques between nerve cells (neurons) within the brain. Amyloid is a widespread term for protein fragments that the body produces typically. Beta amyloid is a protein fragment snipped from an amyloid precursor protein (APP). In a healthy mind, those protein fragments are broken down and removed. In Alzheimer's ailment, the fragments accumulate to shape tough, insoluble plaques.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related conferences: 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019

 

Track 11: Dementia with Lewy Bodies:

 Lewy bodies are the ordinary deposits of the protein referred to as alpha-synuclein in the mind. Lewy body Dementia is a neurogenerative ailment characterised through dementia, fluctuations in mental reputation, hallucinations and parkinsonism, it's miles the second one most not unusual purpose of dementia flowing Alzheimers sickness. Alpha-synuclein additionally aggregates in the brains of people with parkinsons ailment but the aggregates may additionally seem in the sample this is exclusive from dementia with Lewy our bodies. LBD can arise alone or in conjunction with other brain issues. Dementia with Lewy bodies and Parkinson's disease dementia. The earliest signs and symptoms range but replicate the equal organic adjustments in the brain. Over time, people with dementia with Lewy bodies or Parkinson's ailment dementia might also broaden comparable signs and symptoms. All medicinal drugs prescribed for LBD are authorized for a direction of remedy for symptoms associated with other sicknesses consisting of Alzheimer’s disease and Parkinson’s disorder with dementia and offer symptomatic blessings for cognitive, motion and behavioral problems. Early and accurate analysis is essential because LBD patients may additionally react to certain medicinal drugs in a different way than AD or PD sufferers. A range of medication, which includes anticholinergics and a few antiparkinsonian medicinal drugs, can get worse LBD signs and symptoms.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019

 

Track 12: Dementia Nursing and Care:

The threat of growing dementia increases with age, as does the risk of growing long-time period conditions inclusive of arthritis, diabetes and cerebrovascular troubles. People with dementia therefore often have co-present issues. Dementia isn't a everyday part of aging, however the risk of developing dementia increases in antique age. Currently there is no therapy for dementia, the focus of remedy is to slow the progression of the disorder and enable the man or woman with dementia to stay properly. Caring for a person with dementia impacts specific individuals in diverse approaches. In any case, worrying can also be both physically and rationally debilitating. It influences all components of the men and women  existence and might have an effect on them to experience separated, pushed and at instances even discouraged. Dementia awareness of health and social care specialists has took place via the mandatory schooling of the fitness and social care team of workers. The development of dementia impacts on every factor of someone's lifestyles and that of their families/careers, so it's miles crucial for healthcare professionals to understand and help each the character with dementia and their own family members/careers.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy

 

Track 13: Clinical Trials and Case Reports:

The goal of much of the research activity in dementia is to develop interventions for 'treatment' or even 'cure'. The classical bench to bedside paradigm has been disappointing in dementia. There is a long list of putative dementia treatment compounds with favourable pre-clinical and early phase trial data that have been neutral or even potentially harmful when assessed in phase III studies. Lewy body dementia is a common but frequently under diagnosed cause of dementia often mistaken for the more familiar entity of Alzheimer disease. Clinically the distinction is important, because it can have profound implications for management. The diagnosis of Lewy body dementia has important implications. It is associated with a high incidence of neuroleptic sensitivity, necessitating great caution in the use of these common antipsychotic agents. Early studies indicate cholinesterase inhibitors can be beneficial for treating the hallucinations and behavior disturbances that afflict these patients and might also improve cognition.

  • Assessment and care planning
  • Person centered care
  • Behavioral interventions
  • Community care and Family/lay caregiving
  • Psychosocial Research in Dementia

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019.

 

Track 14: Recent Advancements and Therapy:

Treatment of dementia depends on its cause. In the case of most progressive dementias, including Alzheimer's disease, there is no cure and no treatment that slows or stops its progression. But there are drug treatments that may temporarily improve symptoms Epidemiological studies show that, worldwide, the number of people aged over 65 will increase substantially in the next decades and that a considerable proportion of this population will develop dementia. Ample evidence shows that ageing is associated with a high rate of painful conditions, irrespective of cognitive status. The number of patients with dementia who will experience painful conditions is therefore likely to increase. drug and non-drug treatments may help with both cognitive and behavioral symptoms. Researchers are looking for new treatments to alter the course of the disease and improve the quality of life for people with dementia.

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy

 

Track 15: Diagnosis and Treatment:

A diagnosis of dementia requires that at least two core mental functions be impaired enough to interfere with daily living. They are memory, language skills, ability to focus and pay attention, ability to reason and problem-solve, and visual perception. Treatment aims may include maintenance of mental functioning for as long as possible when dementia cannot be reserved, to prevent further strokes in patients with vascular dementia. Several dietary supplements, herbal remedies and therapies have been studied for people with dementia. Treatment modalities include NMDA Antagonists, antipsychotic agents, antidepressants and mood stabilizers and many more..

Related: Dementia Conferences | Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences |

Related Conferences: International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, December 03-04, 2018 , Madrid, Spain; 11th International Conference on Alzheimer's Disease and Dementia, London, UK, June 3-4, 2019; 11th World Congress on Alzheimers Disease & Dementia, March 20-21, 2019 Sydney, Australia; 10th International Conference on Dementia and Dementia Care July 23-24, 2019 , Rome, Italy; 15th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 22-23, 2019; 13th World Congress on Alzheimers and Dementia, December 06-07, 2018; 13th Annual Conference on Dementia and Alzheimers Disease, December 13-15, 2018 Abu Dhabi, UAE; 31st World Congress on Neurology & Neuroscience, March 25-26, 2019 Osaka, Japan; 15th International Conference on Dementia and Alzheimers Disease, March 25-26, 2019 Osaka, Japan; 12th World Congress on Dementia and Alzheimer Rehabilitation, April 11-12, 2019 Stockholm, Sweden; 2nd International Conference on Alzheimer's and Parkinson's Diseases, March 04-06, 2019 at London, UK; 11th International Conference on Vascular Dementia February 15-16, 2019 Amsterdam| Netherlands; 13th World Congress on Dementia and Alzheimer's Disease, MELBOURNE | AUSTRALIA, March 25-26, 2019;; 2nd International Conference on  Dementia and Dementia Care, April 15 -16, 2019.

 

Market Analysis

Dementia along with Alzheimer’s disorder, is certainly one of the most important international public fitness challenges and ailment going through our era. Vascular dementia is the second maximum common motive of dementia due to brain damage almost 60-70% of Alzheimer's disorder is the motive of dementia. Many researchers take into account an increase in the degree of protein amyloid within the brain is one of the reasons of Alzheimer ailment. Older age is the distinguished cause of Alzheimer's, while there are also some genetic and a few other reasons of Alzheimer sicknesses. The genuine cause of Alzheimer’s ailment is still unknown. The international Alzheimer’s market is in particular driven by using the growing incidence of sicknesses in developed international locations especially inside the Western place. The growing occurrence of Alzheimer’s sickness is in particular attributed to the developing range of human beings over the age of 65. Although some instances of younger-onset have befell, that is defined as Alzheimer’s symptoms in humans underneath the age of 65. Alzheimer’s ailment is anticipated to affect up to 6% of the population over 65.

 

Why Australia:

Dementia is the second prominent cause of death of Australians contributing to 5.4% of all deaths in males and 10.6% of all deaths in females every year

  • In 2016 dementia became the primary cause of death among Australian females, exceeding heart disease which has been the primary cause of death for both males and females since the early 20th century. Females account for 64.4% of all dementia related deaths
  • In 2018, there is an expected 425,416 Australians living with dementia (191,367 (45%) males and 234,049 (55%) females)
  • Without a medical advancement, the number of people with dementia is anticipated to increase to an estimated 536,164 by 2025 and 1,100,890 by 2056
  • Currently, an expected 250 people are joining the population with dementia every day. The sum of new cases of dementia is likely to increase to an estimated 318 people per day by 2025 and more than 650 people per day by 2056
  • Three in 10 people over the age of 85 and almost one in 10 people over 65 have dementia
  • In 2018, there is an estimated 26,443 people with younger onset dementia, estimated to rise to 29,375 people by 2025 and 42,252 people by 2056
  • An average of 36 people died per day where dementia was the underlying source of death in 2016. Of the 13,126 people that lost their lives, 8,447 were female

 

The graph illustrates the ratio and the increase of the number of cases of dementia all across thee world in the recent years and the forthcoming days. Researchers are looking for new treatments to alter the course of the disease and improve the quality of life for people with dementia.

 

Neurology Associations all across the world:

  • Alzheimer's Association
  • European Neurological Societies
  • Alzheimer Society of Bangladesh
  • Barbados Alzheimer's Association Inc.
  • World Federation of Neurology
  • Association de Lucha contra el Mal de Alzheimer
  • Alzheimer's Family Support Group
  • Ligue National Alzheimer Liga
  • Corporation Alzheimer Chile
  • Alzheimer Association & Societies in Canada
  • American Academy of Neurology
  • FEBRAZ - Federico Brasilia de Associaçãoes de Alzheimer
  • Alzheimer's disease Chinese
  • Spanish Society of Neurology
  • Major Neurological Associations in Italy
  • Alzheimer’s and Dementia Association of The Cayman Islands
  • Southern Clinical Neurological Society
  • ESNR European Society of Neuroradiology

 

Past Conference Report

Alzheimers Congress 2018

10th World Congress on Alzheimers disease and Dementia was organized during May 30-31, 2018 at Hyatt Regency Osaka, Osaka, Japan with the support and contribution of the Organizing Committee Members. We extend our grateful thanks to all the participants in trusting us and standing by our side in Alzheimers Congress 2018, a global platform to discuss various important aspects of Alzheimers disease and Dementia and making the event successful.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 15 countries, who have driven this event into the path of success. The conference witnessed an amalgamation of peerless speeches, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neuroscience and various Neurological disorders by their fabulous presentations at the podium of Alzheimer’s Congress 2018

The conference was organized around the theme “Novel Research and Diagnostic Approaches of Alzheimers Disease and Dementia”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological disorders and management of Alzheimer’s disease and Dementia with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:  

Nela Pivac, Rudjer Boskovic Institute, Croatia

Bruno Vincent, Mahidol University, Thailand

Reshma A Merchant, National University of Singapore, Singapore

Dong-Woo Lee, Inje University Sanggye Paik Hospital, Republic of Korea

Philip Choo, National Healthcare Group, Singapore

Claude Michel Wischik, University of Aberdeen, UK

Benedicte Defontaines, Hospital Center De Moze, France

 

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank our Organizing Committee Members.

So as a continuation of Alzheimers Congress 2018, we would like to heartily invite you to our upcoming 14th World Congress on Advances in Alzheimers and Dementia scheduled during May 15-16, 2019 at Melbourne, Australia. Your expertise and knowledge in the area of Alzheimer and Dementia will provide an oppor­tunity to discuss and respond to a series of questions about the status of Alzheimer’s disease and Dementia.

We look forward to seeing your benign presence with active contribution and support to make this event successful once more.

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 15-16, 2019

Speaker Opportunity

Supported By

Brain Disorders & Therapy Journal of Alzheimers Disease & Parkinsonism Journal of Neurological Disorders

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos